2022
DOI: 10.1101/2022.01.09.475410
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Genetic Impairment of Succinate Metabolism Disrupts Bioenergetic Sensing in Adrenal Neuroendocrine Cancer

Abstract: Metabolic dysfunction mutations can impair energy sensing and cause cancer. Loss of function of mitochondrial TCA cycle enzyme, succinate dehydrogenase B (SDHB) results in various forms of cancer typified by pheochromocytoma (PC). Here we delineate a signaling cascade where the loss of SDHB induces the Warburg effect in PC tumors, triggers dysregulation of Ca2+ homeostasis, and aberrantly activates calpain and the protein kinase Cdk5, through conversion of its cofactor from p35 to p25. Consequently, aberrant C… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 112 publications
0
1
0
Order By: Relevance
“…While this lack of specificity is most frequently evidenced by in vitro phosphorylation effects, where the drugs can act at their highest potency on purified and often recombinant kinases, within the intracellular milieu, conditions and interactions with other proteins or cell constituents may afford different or even more selective inhibition profiles ( Knight and Shokat, 2005 ; Smyth and Collins, 2009 ). Indeed, other Cdk5 inhibitors in this class of molecules have been shown to be more selective for Cdk5 than Cdk1/2 in cultured cells ( Pozo et al, 2013 ; Gupta et al, 2022 ). However, any off-target or toxic effects of systemic inhibition of Cdk2 by 25–106 remain unknown.…”
Section: Discussionmentioning
confidence: 99%
“…While this lack of specificity is most frequently evidenced by in vitro phosphorylation effects, where the drugs can act at their highest potency on purified and often recombinant kinases, within the intracellular milieu, conditions and interactions with other proteins or cell constituents may afford different or even more selective inhibition profiles ( Knight and Shokat, 2005 ; Smyth and Collins, 2009 ). Indeed, other Cdk5 inhibitors in this class of molecules have been shown to be more selective for Cdk5 than Cdk1/2 in cultured cells ( Pozo et al, 2013 ; Gupta et al, 2022 ). However, any off-target or toxic effects of systemic inhibition of Cdk2 by 25–106 remain unknown.…”
Section: Discussionmentioning
confidence: 99%